Abstract:Objective Angiopoietin-1 (Ang-1) and Angiopoietin-2 (Ang-2) are the members of angiopoietin families. The regulation between Ang-1 and Ang-2 plays an important role in accommodating endothelial cell function and inflammation. Several recent studies have demonstrated that Ang-1, Ang-2 levels and ratio can strongly predict the condition and prognosis in several inflammatory related diseases. However, there were a little study on the changes and clinical significance of Ang-1 and Ang-2 in the patients with coronary heart disease and whether they may be used to predict disease severity are still unknown. The aim of our study is to investigate the Ang-1, Ang-2 levels and ratio changes and some conceivably influential factors in different type of patients with CHD, explore the predictive value for disease severity and plaque stability. Methods We studied 166 patients admitted to the ward of Cardiology Department in Peking University Third Hospital between September 2010 and April 2011. They were divided into five groups: 35 STEMI, 26 NSTEMI, 40 UA, 40 SA patients and 25 controls. The serum samples were collected before coronary arteriography. Serum concentrations of Ang-1 and Ang-2 were tested by ELISA. Results (1) The serum levels of Ang-1 Ang-2 and Ang-2/Ang-1 ratio in patients with SA, UA, NSTEMI and STEMI were significantly higher than those in the controls (p<0.001). (2) Ang-1 and Ang-2 levels in patients with SA, UA, NSTEMI and STEMI increased gradually with significant difference between each two groups (p<0.001). Ang-2/Ang-1 ratio was significantly different in each two groups (p<0.05), but not SA and UA groups (p>0.05). (3) Compared with SA group, the levels of Ang-1, Ang-2 and Ang-2/Ang-1 ratio were significantly higher in ACS group (p<0.001). (4) By correlation analysis, Ang-1, Ang-2 and Ang-2/Ang-1 ratio in patients with CHD were positively related to Gensini scores (p<0.01). (5) Ang-1 was positively correlative to Neu (p<0.05), WBC, Neu%, hs-CRP, LDL-c, Glu and Fib (p<0.01), but was negatively correlative to LVEF (p<0.01). Ang-2 was positively related to hypertension, Neu, LDL-c (p<0.05), WBC, Neu%, hs-CRP, Glu and Fib (p<0.01), but was negatively related to LVEF (p<0.01). Ang-2/Ang-1 ratio had positive relationship with Hypertension, hs-CRP, Fib (p<0.05), WBC, Neu% and Glu (p<0.01), but had negative relationship with LVEF (p<0.01). (6) In AMI patients, Ang-1, Ang-2 and Ang-2/Ang-1 ratio were significant positive correlation to peak CK, CKMB and TnT levels (p<0.01). Conclusion The serum levels of Ang-1, Ang-2 and Ang-2/Ang-1 ratio change significantly in different type of coronary heart disease, which could be used to evaluate the disease severity. Moreover, they may become important biomarkers to predict the stability of coronary plaque.

Changes in plasma monocyte chemoattractant protein-1 in patients with acute coronary syndrome and patients with restenosis after angioplasty

Characteristics, prognostic determinants of monocytes, macrophages and T cells in acute coronary syndrome: protocol for a multicenter, prospective cohort study

The Study of the Relation Between C-reactive Protein,fibrinogen and Acute Coronary Syndrome

The clinic relevance between acute coronary syndrome and the level of serum matrix metalloproteinase-9

Study on the Relationship between Serum Resistin and Acute Coronary Syndrome and Stable Angina Pectoris

[Changes of Plasma High-Sensitive C-reactive Protein and Monocyte Chemotactic Factor-1 Following Percutaneous Coronary Interventional Procedures in Patients with Coronary Artery Disease].

Relationship Between Serum Concentrations of IL-18, IL-10, IL-6 and Acute Coronary Syndrome

The Changes of Secretory Type Ⅱ Phospholipase A2 in Coronary Heart Disease and Its Relationship with High Sensifive-C Reactive Protein

Clinical Significance of the Changes of Plasma Adiponectin Levels in Patients with Coronary Artery Disease

Temporal Changes in Circulating P-selectin, Plasminogen Activator Inhibitor-1, Magnesium, and Creatine Kinase after Percutaneous Coronary Intervention

Changes and Implication of Peripheral Blood Levels of Matrix Metalloproteases-9 and C-reactive Protein in Patients with Coronary Artery Disease

Changes of monocyte chemotactic protein-1 after coronary microembolization

Changes of Plasma Macrophage Migration Inhibitory Factor Level in Patients with Acute Myocardial Infarction and Its Clinical Significance

Monocyte Chemoattractant Protein-1, Inflammatory Biomarkers, and Prognosis of Patients With Ischemic Stroke or Transient Ischemic Attack: Fndings From a Nationwide Registry Study

Changes of Plasma Levels of Homocysteine and MCP-1 in Patients with Coronary Artery Disease

Continuous Observation and Implication of MMP-9 in Peripheral Blood in Patients with Acute Coronary Syndromes after PCI

The Expressions of MMP-9 and TIMP-1 Mrna in Circulating Monocytes of Patients with ACS

The Changes of the Levels of Plasma Oxidized Low Density Lipoprotein, High-Sensitivity C-Reactive Protein and its Relation to the Endothelial Injury in Patients with Acute Coronary Syndrome

Changes and Significance of Serum Angiopoietin-1 and Angiopoietin-2 Levels in Patients with Coronary Heart Disease

Serum concentrations of high-sensitivity C-reactive protein predict progressively obstructive lesions rather than late restenosis in patients with unstable angina undergoing coronary artery stenting

Prognostic Value of Highly Sensitive C-reactive Protein and Plaquemorphology in Coronary Artery Disease in China.